Novel neuropeptides in the pathophysiology of heart failure: adrenomedullin and endothelin-1

The clinical success of neurohumoral manipulation by ACE inhibitors and beta blockers in heart failure has led to new therapeutic approaches. New neurohumoral factors are now viewed as offering the potential for treatment interventions. Not only do we consider blocking the production of deleterious...

Full description

Saved in:
Bibliographic Details
Published in:European journal of heart failure 1999-03, Vol.1 (1), p.25-29
Main Authors: Petrie, Mark C., McClure, Samuel J., Love, Michael P., McMurray, John J.V.
Format: Article
Language:English
Subjects:
Adrenomedullin
Atrial Natriuretic Factor - physiology
Endothelin-1 - physiology
Heart Failure - physiopathology
Humans
Natriuretic Peptide, Brain - physiology
Peptides - physiology
Vasoconstriction - physiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The clinical success of neurohumoral manipulation by ACE inhibitors and beta blockers in heart failure has led to new therapeutic approaches. New neurohumoral factors are now viewed as offering the potential for treatment interventions. Not only do we consider blocking the production of deleterious hormones, but also, more recently, consideration has been given to augmenting the actions of factors with potentially beneficial actions. Hopefully such manipulation of ADM and ET-1 can result in further improvement in the well-being of heart failure patients.
ISSN:1388-9842
1879-0844
DOI:10.1016/S1388-9842(98)00013-0